Drugs Market Research Reports & Industry Analysis

The drugs industry is an enormous multibillion businesses encompassing an immense number of companies involved in the design, production and marketing of drugs worldwide. According to the type of drugs the market can be dived into the following segments: diabetes, antifungal, antidepressant, antithrombotic, hepatitis drugs, analgesics and a far more.

Currently, the drugs market is undergoing a recovery phase in the wake of the recent decline provoked by the economic slump. The market growth is spurred by increasing demand for drugs across the globe, rising incidence of chronic as well as infectious diseases, population ageing, product innovations and constant technological advancements. North America and Europe are the most prominent regional markets. Bristol-Myers Squibb, Pharmacia, GlaxoSmithKline, Merck & Co, Novartis, Eli Lilly, Pfizer, Johnson & Johnson, Allergan, Schering-Plough, Bayer and Abbott Labs are amid global drugs arena giants.

A huge collection of the research reports covering the drugs market at different geographies can be found under this MarketPublishers’ catalogue. The researches provide comprehensive assessment of the market, characterize major market trends and disclose essential market indicators. The reports describe the competitive scenario and indicate top market players. In addition, future prospects for the drugs market are thoroughly studied in the research reports.

Publications found: 10,876
Sort by:

Investigation Report on China's Metformin Market, 2018-2022

US$ 2,200.00

... to grow in China in the next few years. Topics Covered: Incidence of type 2 diabetes in China Size of China's Metformin market Competition on China's Metformin market Retail prices of Metformin in China Prospect of China's Metformin market

November 2018 30 pages

Investigation Report on China's Metoprolol Market, 2018-2022

US$ 2,200.00

... potential in China. Topics Covered: Situation of hypertension in China Sales of Metoprolol in China Major Metoprolol manufacturers in China Competition on China's Metoprolol market Driving forces and opportunities for China's Metoprolol market Forecasts on China's Metoprolol market ...

November 2018 30 pages

Global Therapeutic Drug Monitoring (TDM) Market - Forecasts From 2018 to 2023

US$ 3,950.00

... global therapeutic drug monitoring market is projected to grow at a CAGR of 6.49%, increasing from US$1.457 billion in 2017 to US$2.125 billion in 2023. Therapeutic Drug Monitoring (TDM) is the measurement of the specific drugs ... understanding of the global therapeutic drug monitoring market. Major industry ...

November 2018 112 pages

Investigation Report on China Entecavir 2018-2022

US$ 2,200.00

... CRI’s market survey, the annual sales value of entecavir in China rose from CNY1126.04 million in 2013 to CNY 1995 ... covered market size of entecavir in China competitive landscape of entecavir in Chinese market price of entecavir made by different manufacturers in China market outlook of entecavir in China

November 2018 30 pages

Investigation Report on China's Acarbose Market, 2018-2022

US$ 2,200.00

... is rising. In 2017, the market size of Acarbose in China was about CNY 1.09 billion. Bayer's market share ... Development environment of Acarbose in China Supply of and demand for Acarbose in China Competition on China's Acarbose market Prices of Acarbose in China Forecasts on China's Acarbose market from 2018 ...

November 2018 30 pages

Investigation Report on China's Insulin Aspart Market, 2018-2022

US$ 2,200.00

... of Insulin Aspart in China will maintain rapid growth in the next few years. Topics Covered: Situation of diabetes in China Sales of Insulin Aspart in China Prices of Insulin Aspart in China Progress of generic Insulin Aspart in China Prospect of China's Insulin Aspart market ...

November 2018 30 pages

Investigation Report on China's Omeprazole Market, 2018-2022

US$ 2,200.00

... certain growth potential in China. Topics Covered: Situation of gastric ulcer in China Sales of Omeprazole in China Competition on China's Omeprazole market Major Omeprazole manufacturers in China Prices of Omeprazole in China Prospect of China's Omeprazole market from 2018 ...

October 2018 30 pages

Investigation Report on China's Repaglinide Market, 2018-2022

US$ 2,200.00

... . Topics Covered: Situation of type 2 diabetes in China Size of China's Repaglinide market Major Repaglinide manufacturers in China Competition on China's Repaglinide market Retail prices of Repaglinide in China Prospect of China's Repaglinide market from 2018 to 2022

October 2018 30 pages

Antibiotics Market by Class (Beta Lactam & Beta Lactamase, Quinolones, Macrolides, and Others), Drug Origin (Natural, Semisynthetic, and Synthetic), Spectrum of Activity (Broad-spectrum Antibiotic and Narrow-spectrum Antibiotic), and Route of Administration (Oral, Intravenous, and Others): Global Opportunity Analysis and Industry Forecast, 2018 - 2025

US$ 5,370.00

... allow companies to strategically plan their business moves. Antibiotics Key Market Segments: By Class Beta Lactam & Beta Lactamase Inhibitors Penicillin Cephalosporin Carbapenem Monobactam Quinolones Macrolides ...

October 2018 282 pages

Global Immunosuppressive Drug Market Research and Forecast, 2018-2023

US$ 3,600.00

... segments: Global immunosuppressive drug market research and analysis, by application Global immunosuppressive drug market research and analysis, by drug type THE REPORT COVERS: Comprehensive research methodology of the global immunosuppressive drug market. Immunosuppressive drug report also ...

October 2018 -

Global Vitamin K1 Market Outlook 2018-2023

US$ 3,000.00

... Global Market for vitamin K1 to 2023 offers detailed coverage of vitamin K1 industry and presents main market trends. The market research gives historical and forecast market ... the vitamin K1. Report contents include Analysis of the vitamin K1 market including revenues, future growth, market outlook Historical ...

October 2018 143 pages

Global Cardio-Protective Drug Market Research and Forecast, 2018-2023

US$ 3,600.00

... government policies impacting the global cardio-protective drug market. Insights about market determinants which are stimulating the Global Cardioprotective drug market. Detailed and extensive market segments with regional ...

October 2018 -

Transdermal Drug Delivery System Market - Forecasts from 2018 to 2023

US$ 3,950.00

... transdermal drug delivery system market is estimated to register a CAGR of 8.91% over the forecast period of 2017-2023. Transdermal drug delivery involves delivering the drug the medications in systemic ... understanding of the global transdermal drug delivery system market. Major industry players profiled ...

October 2018 100 pages

Global Antidepressant Drugs Market Forecast up to 2018 – 2024

US$ 2,750.00

... a challenge faced globally. Market Analysis: The “global antidepressant drugs market” is estimated to witness a CAGR of 2.2% during the forecast period 2018–2024. The global antidepressant drugs market is analyzed based on drug class and regions ...

October 2018 104 pages

Cinryze - Drug Insights, 2018

US$ 1,000.00

... the historical and forecasted sales of Cinryze till 2022. The report also throws light on Cinryze`s market competition and emerging therapies in the same space as Cinryze. A SWOT analysis of the drug is also ...

October 2018 34 pages

Global Intravenous (IV) Iron Drugs Market: Size, Trends and Forecasts (2018-2022)

US$ 1,600.00

... of intravenous (IV) iron drugs market produce intravenous iron drugs for different indications, with different iron content and in different doses. However, the competition in the global intravenous (IV) iron drugs market is dominated by few intravenous iron drugs ...

September 2018 102 pages

Global Parkinson's Disease Drugs Market 2018-2024

US$ 3,250.00

... functionality. This is demanding more innovative and novel drugs for the treatment. Market Analysis: The “Global Parkinson’s Disease Drugs Market” is estimated to witness a CAGR of 7.2% during the forecast ...

September 2018 110 pages

African Trypanosomiasis Infection Drug Pipeline Study, H2 2018- Analysis of Phases, Companies, Mechansim, Trials, Current Status of Pipeline Drugs for African Trypanosomiasis

US$ 1,080.00

African Trypanosomiasis Infection Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of African Trypanosomiasis Infection pipeline products. DISEASE OVERVIEW African Trypanosomiasis infection is spread through Clostridium tetani bacteria ...

September 2018 65 pages

Bacillary Dysentery (Shigellosis) Infection Drug Pipeline Study, H2 2018- Analysis of Phases, Companies, Mechansim, Trials, Current Status of Pipeline Drugs for Bacillary Dysentery (Shigellosis)

US$ 1,080.00

Bacillary Dysentery (Shigellosis) Infection Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Bacillary Dysentery (Shigellosis) Infection pipeline products. DISEASE OVERVIEW Bacillary Dysentery (Shigellosis) infection is spread through ...

September 2018 65 pages

Bacterial Vaginosis Infection Drug Pipeline Study, H2 2018- Analysis of Phases, Companies, Mechansim, Trials, Current Status of Pipeline Drugs for Bacterial Vaginosis

US$ 1,080.00

Bacterial Vaginosis Infection Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Bacterial Vaginosis Infection pipeline products. DISEASE OVERVIEW Bacterial Vaginosis infection is spread through Clostridium tetani bacteria ...

September 2018 65 pages

Candidiasis Infection Drug Pipeline Study, H2 2018- Analysis of Phases, Companies, Mechansim, Trials, Current Status of Pipeline Drugs for Candidiasis

US$ 1,080.00

Candidiasis Infection Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Candidiasis Infection pipeline products. DISEASE OVERVIEW Candidiasis infection is spread through Clostridium tetani bacteria, which ...

September 2018 65 pages

Cholera Infection Drug Pipeline Study, H2 2018- Analysis of Phases, Companies, Mechansim, Trials, Current Status of Pipeline Drugs for Cholera

US$ 1,080.00

Cholera Infection Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Cholera Infection pipeline products. DISEASE OVERVIEW Cholera infection is spread through Clostridium tetani bacteria, which ...

September 2018 65 pages

Coccidioidomycosis Infection Drug Pipeline Study, H2 2018- Analysis of Phases, Companies, Mechansim, Trials, Current Status of Pipeline Drugs for Coccidioidomycosis

US$ 1,080.00

Coccidioidomycosis Infection Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Coccidioidomycosis Infection pipeline products. DISEASE OVERVIEW Coccidioidomycosis infection is spread through Clostridium tetani bacteria, which ...

September 2018 65 pages

Cryptococcosis Infection Drug Pipeline Study, H2 2018- Analysis of Phases, Companies, Mechansim, Trials, Current Status of Pipeline Drugs for Cryptococcosis

US$ 1,080.00

Cryptococcosis Infection Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Cryptococcosis Infection pipeline products. DISEASE OVERVIEW Cryptococcosis infection is spread through Clostridium tetani bacteria, which ...

September 2018 65 pages

Eastern Equine Encephalitis Infection Drug Pipeline Study, H2 2018- Analysis of Phases, Companies, Mechansim, Trials, Current Status of Pipeline Drugs for Eastern Equine Encephalitis

US$ 1,080.00

Eastern Equine Encephalitis Infection Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Eastern Equine Encephalitis Infection pipeline products. DISEASE OVERVIEW Eastern Equine Encephalitis infection is spread through Clostridium ...

September 2018 65 pages

Epstein–Barr Virus (HHV-4) Infections Infection Drug Pipeline Study, H2 2018- Analysis of Phases, Companies, Mechansim, Trials, Current Status of Pipeline Drugs for Epstein–Barr Virus (HHV-4) Infections

US$ 1,080.00

... format. SCOPE OF EPSTEIN–BARR VIRUS (HHV-4) INFECTIONS INFECTION PIPELINE REPORT INCLUDES Panorama of Epstein–Barr Virus (HHV-4) Infections Infection pipeline markets including statistics on therapeutic drugs and companies involved Epstein–Barr Virus (HHV-4) Infections Infection Pipeline candidates across ...

September 2018 65 pages

Equine Encephalitis Infection Drug Pipeline Study, H2 2018- Analysis of Phases, Companies, Mechansim, Trials, Current Status of Pipeline Drugs for Equine Encephalitis

US$ 1,080.00

Equine Encephalitis Infection Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Equine Encephalitis Infection pipeline products. DISEASE OVERVIEW Equine Encephalitis infection is spread through Clostridium tetani bacteria ...

September 2018 65 pages

Genital Herpes Infection Drug Pipeline Study, H2 2018- Analysis of Phases, Companies, Mechansim, Trials, Current Status of Pipeline Drugs for Genital Herpes

US$ 1,080.00

Genital Herpes Infection Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Genital Herpes Infection pipeline products. DISEASE OVERVIEW Genital Herpes infection is spread through Clostridium tetani bacteria ...

September 2018 65 pages

Gonorrhea Infection Drug Pipeline Study, H2 2018- Analysis of Phases, Companies, Mechansim, Trials, Current Status of Pipeline Drugs for Gonorrhea

US$ 1,080.00

Gonorrhea Infection Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Gonorrhea Infection pipeline products. DISEASE OVERVIEW Gonorrhea infection is spread through Clostridium tetani bacteria, which ...

September 2018 65 pages

Influenza A Virus H3N2 Subtype Infection Drug Pipeline Study, H2 2018- Analysis of Phases, Companies, Mechansim, Trials, Current Status of Pipeline Drugs for Influenza A Virus H3N2 Subtype

US$ 1,080.00

... . SCOPE OF INFLUENZA A VIRUS H3N2 SUBTYPE INFECTION PIPELINE REPORT INCLUDES Panorama of Influenza A Virus H3N2 Subtype Infection pipeline markets including statistics on therapeutic drugs and companies involved Influenza A Virus H3N2 Subtype Infection Pipeline ...

September 2018 65 pages

Influenza A virus H5N1 subtype Infection Drug Pipeline Study, H2 2018- Analysis of Phases, Companies, Mechansim, Trials, Current Status of Pipeline Drugs for Influenza A virus H5N1 subtype

US$ 1,080.00

... . SCOPE OF INFLUENZA A VIRUS H5N1 SUBTYPE INFECTION PIPELINE REPORT INCLUDES Panorama of Influenza A virus H5N1 subtype Infection pipeline markets including statistics on therapeutic drugs and companies involved Influenza A virus H5N1 subtype Infection Pipeline ...

September 2018 65 pages

Influenza A Virus H7N9 Infection Drug Pipeline Study, H2 2018- Analysis of Phases, Companies, Mechansim, Trials, Current Status of Pipeline Drugs for Influenza A Virus H7N9

US$ 1,080.00

... format. SCOPE OF INFLUENZA A VIRUS H7N9 INFECTION PIPELINE REPORT INCLUDES Panorama of Influenza A Virus H7N9 Infection pipeline markets including statistics on therapeutic drugs and companies involved Influenza A Virus H7N9 Infection Pipeline candidates across ...

September 2018 65 pages

Lassa Hemorrhagic Fever Infection Drug Pipeline Study, H2 2018- Analysis of Phases, Companies, Mechansim, Trials, Current Status of Pipeline Drugs for Lassa Hemorrhagic Fever

US$ 1,080.00

Lassa Hemorrhagic Fever Infection Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Lassa Hemorrhagic Fever Infection pipeline products. DISEASE OVERVIEW Lassa Hemorrhagic Fever infection is spread through Clostridium ...

September 2018 65 pages

Marburgvirus Infections Infection Drug Pipeline Study, H2 2018- Analysis of Phases, Companies, Mechansim, Trials, Current Status of Pipeline Drugs for Marburgvirus Infections

US$ 1,080.00

... ready to use format. SCOPE OF MARBURGVIRUS INFECTIONS INFECTION PIPELINE REPORT INCLUDES Panorama of Marburgvirus Infections Infection pipeline markets including statistics on therapeutic drugs and companies involved Marburgvirus Infections Infection Pipeline candidates across various development ...

September 2018 65 pages

Meningitis Infection Drug Pipeline Study, H2 2018- Analysis of Phases, Companies, Mechansim, Trials, Current Status of Pipeline Drugs for Meningitis

US$ 1,080.00

Meningitis Infection Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Meningitis Infection pipeline products. DISEASE OVERVIEW Meningitis infection is spread through Clostridium tetani bacteria, which ...

September 2018 65 pages

Osteomyelitis Infection Drug Pipeline Study, H2 2018- Analysis of Phases, Companies, Mechansim, Trials, Current Status of Pipeline Drugs for Osteomyelitis

US$ 1,080.00

Osteomyelitis Infection Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Osteomyelitis Infection pipeline products. DISEASE OVERVIEW Osteomyelitis infection is spread through Clostridium tetani bacteria, which ...

September 2018 65 pages

Plague Infection Drug Pipeline Study, H2 2018- Analysis of Phases, Companies, Mechansim, Trials, Current Status of Pipeline Drugs for Plague

US$ 1,080.00

Plague Infection Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Plague Infection pipeline products. DISEASE OVERVIEW Plague infection is spread through Clostridium tetani bacteria, which ...

September 2018 65 pages

Poliomyelitis Infection Drug Pipeline Study, H2 2018- Analysis of Phases, Companies, Mechansim, Trials, Current Status of Pipeline Drugs for Poliomyelitis

US$ 1,080.00

Poliomyelitis Infection Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Poliomyelitis Infection pipeline products. DISEASE OVERVIEW Poliomyelitis infection is spread through Clostridium tetani bacteria, which ...

September 2018 65 pages

Pyelonephritis Infection Drug Pipeline Study, H2 2018- Analysis of Phases, Companies, Mechansim, Trials, Current Status of Pipeline Drugs for Pyelonephritis

US$ 1,080.00

Pyelonephritis Infection Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Pyelonephritis Infection pipeline products. DISEASE OVERVIEW Pyelonephritis infection is spread through Clostridium tetani bacteria, which ...

September 2018 65 pages

Rhinovirus Infection Drug Pipeline Study, H2 2018- Analysis of Phases, Companies, Mechansim, Trials, Current Status of Pipeline Drugs for Rhinovirus

US$ 1,080.00

Rhinovirus Infection Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Rhinovirus Infection pipeline products. DISEASE OVERVIEW Rhinovirus infection is spread through Clostridium tetani bacteria, which ...

September 2018 65 pages

Schistosomiasis Infection Drug Pipeline Study, H2 2018- Analysis of Phases, Companies, Mechansim, Trials, Current Status of Pipeline Drugs for Schistosomiasis

US$ 1,080.00

Schistosomiasis Infection Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Schistosomiasis Infection pipeline products. DISEASE OVERVIEW Schistosomiasis infection is spread through Clostridium tetani bacteria, which ...

September 2018 65 pages

Severe Acute Respiratory Syndrome (SARS) Infection Drug Pipeline Study, H2 2018- Analysis of Phases, Companies, Mechansim, Trials, Current Status of Pipeline Drugs for Severe Acute Respiratory Syndrome (SARS)

US$ 1,080.00

... . SCOPE OF SEVERE ACUTE RESPIRATORY SYNDROME (SARS) INFECTION PIPELINE REPORT INCLUDES Panorama of Severe Acute Respiratory Syndrome (SARS) Infection pipeline markets including statistics on therapeutic drugs and companies involved Severe Acute Respiratory Syndrome (SARS) Infection Pipeline ...

September 2018 65 pages

Shingles Infection Drug Pipeline Study, H2 2018- Analysis of Phases, Companies, Mechansim, Trials, Current Status of Pipeline Drugs for Shingles

US$ 1,080.00

Shingles Infection Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Shingles Infection pipeline products. DISEASE OVERVIEW Shingles infection is spread through Clostridium tetani bacteria, which ...

September 2018 65 pages

Tinea pedis (Athlete Foot) Infection Drug Pipeline Study, H2 2018- Analysis of Phases, Companies, Mechansim, Trials, Current Status of Pipeline Drugs for Tinea pedis (Athlete Foot)

US$ 1,080.00

... format. SCOPE OF TINEA PEDIS (ATHLETE FOOT) INFECTION PIPELINE REPORT INCLUDES Panorama of Tinea pedis (Athlete Foot) Infection pipeline markets including statistics on therapeutic drugs and companies involved Tinea pedis (Athlete Foot) Infection Pipeline candidates across ...

September 2018 65 pages

Toxoplasmosis Infection Drug Pipeline Study, H2 2018- Analysis of Phases, Companies, Mechansim, Trials, Current Status of Pipeline Drugs for Toxoplasmosis

US$ 1,080.00

Toxoplasmosis Infection Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Toxoplasmosis Infection pipeline products. DISEASE OVERVIEW Toxoplasmosis infection is spread through Clostridium tetani bacteria, which ...

September 2018 65 pages

Warts Infection Drug Pipeline Study, H2 2018- Analysis of Phases, Companies, Mechansim, Trials, Current Status of Pipeline Drugs for Warts

US$ 1,080.00

Warts Infection Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Warts Infection pipeline products. DISEASE OVERVIEW Warts infection is spread through Clostridium tetani bacteria, which ...

September 2018 65 pages

West Nile Virus Infection Drug Pipeline Study, H2 2018- Analysis of Phases, Companies, Mechansim, Trials, Current Status of Pipeline Drugs for West Nile Virus

US$ 1,080.00

West Nile Virus Infection Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of West Nile Virus Infection pipeline products. DISEASE OVERVIEW West Nile Virus infection is spread through Clostridium ...

September 2018 65 pages

Western Equine Encephalitis Infection Drug Pipeline Study, H2 2018- Analysis of Phases, Companies, Mechansim, Trials, Current Status of Pipeline Drugs for Western Equine Encephalitis

US$ 1,080.00

Western Equine Encephalitis Infection Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Western Equine Encephalitis Infection pipeline products. DISEASE OVERVIEW Western Equine Encephalitis infection is spread through Clostridium ...

September 2018 65 pages

Antipsychotic Drugs: Technologies and Global Markets

US$ 2,750.00

... market for antipsychotic drugs. The report highlights the current and future market potential of antipsychotic drugs and provides a detailed analysis of the competitive environment, regulatory scenario, technological ... of the global market for antipsychotic drugs Analyses of global market trends, with data from ...

September 2018 174 pages

Investigation Report on China's Gliclazide Market, 2018-2022

US$ 2,200.00

... of Servier, the company has been taking the leading position on China's Gliclazide market. Also dominating the market are Servier and Servier ... rising after the drug entered China, and exceeded CNY 200 million in 2017. It is expected that China's Gliclazide market will continue to grow as the ...

September 2018 30 pages

Filters

Search

Publishers

1
450
353
174
29
4
837
409
36
27
2,279
77
19
16
2
21
1
16
1
9
9
2,264
5
4
31
6
142
1
17
15
248
651
91
1
373
26
34
724
1
2
16
6
4
84
36
3
4
2
7
15
53
16
26
83
11
32
8
2
17
106
27
19
4
7
3
324
15
1
23
86
24
28
44
296
17
18
2

Regions

131
40
38
37
37
35
32
23
13
10
10
9
9
8
8
8
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
6
6
6
6
6
6
5
5
5
5
4
4
3
3
3
3
3
91
12
354
30
6
6
4
4
4
4
4
4
4
4
4
4
4
4
4
3
3
3
3
3
3
3
3
2
2
39
6
4
3
3
3
1
1
3
7
9,529

Price

—

Date

—

Pages

—

Offers

9
1